Pancreatic Enzyme Supplement (Canada)

This page contains information on Pancreatic Enzyme Supplement for veterinary use.
The information provided typically includes the following:
  • Pancreatic Enzyme Supplement Indications
  • Warnings and cautions for Pancreatic Enzyme Supplement
  • Direction and dosage information for Pancreatic Enzyme Supplement

Pancreatic Enzyme Supplement

This treatment applies to the following species:
Manufacturer: Partnar Animal Health

Pancrelipase Powder USP 100% w/w

DIN 02304031

Veterinary Use Only

Warning

KEEP OUT OF REACH OF CHILDREN

Active Ingredients

Each 2.8 g (1 tsp) contains:

Lipase

67,200 USP Units

Protease

280,000 USP Units

Amylase

280,000 USP Units

Each 2.8 g (1 tsp) digests:

Fat

236 g

Protein

280 g

Starch

280 g

INDICATION: For replacement therapy in conditions due to exocrine pancreatic insufficiency in dogs and cats.

Dosage and Administration

Administer orally. Mix powder with pet’s food 20 minutes before feeding.

Dogs: 2.8 - 4.2 g (1 - 1.5 tsp) with each meal.

Cats: 1.4 - 2.1 g (0.5 - 0.75 tsp) with each meal.

Dosage is dependent upon degree of pancreatic insufficiency. Consult your veterinarian for frequency of meals and adjustment of dosage.

Pancreatic Enzyme Supplement Caution

Discontinue use if symptoms of sensitivity occur.

Storage

Store in a tightly closed container in a dry place between 15-25°C.

Partnar Animal Health Inc., 14057 Ilderton Road, Ilderton, Ontario, Canada N0M 2A0

Net

 

131 g

Iss. 03-09

NAC No.: 12890091

PARTNAR ANIMAL HEALTH INC.
14057 ILDERTON ROAD, ILDERTON, ON, N0M 2A0
Telephone:   519-666-0033
Order Desk:   866-690-4998
Fax:   519-666-0699
Website:   www.partnaranimalhealth.ca
Every effort has been made to ensure the accuracy of the Pancreatic Enzyme Supplement information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web2)